| News

DayOne Catalyst Project: Oonida

04.02.2019

One of the pillars of BaselArea.swiss’ DayOne (www.DayOne.swiss) strategy is to drive Catalyst projects – collaborative approaches to bottleneck issues in Healthcare innovation. These are “wicked problems” that can only be solved collaboratively. Therefore, Catalyst Projects focus on challenges to which it is difficult to find solutions within the current industry structures.

DayOne Catalyst project workshop (img: Frank Kumli)
DayOne Catalyst project workshop (img: Frank Kumli)

The access to healthcare data is one of the best-known bottleneck issues in healthcare innovation and is being addressed by Oonida. The Basel based not-for-profit company is building a citizen centric platform where health data can be shared between patients and all relevant healthcare stakeholders. As a neutral steward OoNiDa aims to improve the efficiency within the ecosystem and overall population health by encouraging free flow of information in the health ecosystem so services and care can be delivered more efficiently and innovation can be stimulated.

New insights and connections

On behalf of OoNiDa DayOne brought together 15 volunteering healthcare innovators across industry and disciplines from the Basel ecosystem. During a full-day workshop at the DayOne Innovation Lab in the Technologiepark Basel, the OoNiDa management was able to validate and refine their business model and to come up with a minimal viable product that could be launched and tested in the local market.

“It is a unique experience for a startup in the very early stage like ours, to get access to some of the brightest minds in the Basel Healthcare Innovation Ecosystem. Not only did we gain new insights but could also make most valuable connections to future partners and customers of our platform”, stated Andy Bushell, Founder and CEO of OoNiDa.

Learn more…

… about the workshop with Oonida and about our Catalyst projects www.dayone.ch/projects.

If you or your organization would like to launch a Catalyst project, please contact frank.kumli@baselarea.swiss

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Yokogawa establishes innovation center in Allschwil

The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus will be on driving forward innovation in the field of biotechnology.

Read More
Basel Area Business & Innovation, Innovation, Invest

Basel gains new biotech in Bright Peak

Versant Ventures has made a US$35 million Series A funding commitment to Bright Peak Therapeutics and has now announced the debut of this biotech. It will operate in Basel and San Diego.

Read More
Basel Area Business & Innovation, Innovation, Switzerland Innovation Park

Robots from Basel set to revolutionize surgery

The Werner Siemens Foundation is to invest an additional 12 million Swiss francs in the Miracle project. Researchers at the University of Basel are developing visionary technology for the use of robots in surgery within the framework of this project.

Read More
Basel Area Business & Innovation, Innovation

T3 Pharma raises over 25 million Swiss francs

T3 Pharmaceuticals AG has closed its third financing round, raising over 25 million Swiss francs. The Basel-based startup has developed a bacterial cancer therapy that it now intends to progress to clinical trials.

Read More
Basel Area Business & Innovation, Innovation

Versameb raises 6 million Swiss francs

The Basel-based biopharmaceutical company Versameb has successfully closed a seed financing round. Versameb develops therapies on the basis of mRNA sequences and is now seeking to drive forward the clinical development of its platform devised for this.

Read More
Basel Area Business & Innovation, Innovation

Genedata accelerating drug development

Genedata, a Basel IT company specializing in the life sciences sector, has agreed a collaboration with Thermo Fisher. The integration of their two platforms will help accelerate the development of drugs.

Read More
Basel Area Business & Innovation, Innovation, Invest

Basel is “probably the most productive life sciences location in the world”

Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the Basel Area, as revealed by an Interpharma report. However, the region also shines in an international comparison. Interpharma CEO René Buholzer regards it as “probably the most productive life sciences location in the world”.

Read More
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Basel Area cantons publish joint economic report

The cantons of Basel-Landschaft, Basel-Stadt and Jura have just published their first joint Economic Report. The fundamental environment is described as “good” in the report.

Read More
Basel Area Business & Innovation, Innovation

Resistell receives high-level EU grant

Resistell AG, based in Muttenz in the canton of Basel-Landschaft, has received a grant of up to 2.5 million euros and additional equity capital financing from a European fund with the aim of accelerating innovation. The company is developing the world’s fastest test against antibiotic resistance.

Read More
Novartis Campus
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Switzerland Innovation Park Basel Area Site Novartis Campus

We are happy to present our latest addition to the Switzerland Innovation Park Basel Area: Our site on the Novartis Campus dedicated to digital health provides a focal point to a unique community of digital healthcare experts.

Read More
1 2 3 19

Do you have a question? We'd like to hear from you.